Introduction
Routine infectious disease surveillance is a crucial component of the health system. Surveillance systems require considerable investment of financial and human resources and have the potential to provide essential, timely information for decision-making (Aqil et al. 2009 ). However, these information systems are often not optimally utilized for operational research and informing policies (Gorman 2013) .
Following the outbreak of severe acute respiratory syndrome in 2003, China launched a web-based Infectious Disease Reporting System (IDRS) to strengthen disease surveillance and enhance responsiveness to communicable disease epidemics in the future. In 2005, the Chinese Centre for Disease Control and Prevention (CDC) developed the Tuberculosis Information Management System (TBIMS), a real-time, web-based electronic reporting and recording system, which collects information on tuberculosis (TB) cases from all health facilities responsible for diagnosis and treating TB. In 2011, the TBIMS was restructured into three linked databases covering the following patient groups: all pulmonary TB and extra-pulmonary TB cases; patients with presumptive multidrug-resistant TB (MDR-TB); and confirmed MDR-TB cases. (Wang et al. 2013; Chinese Center for Disease Control and Prevention 2014; Huang et al. 2014) .
Although China has made considerable progress in reducing TB prevalence since 1991, it still has the third highest TB and highest multidrug-resistant tuberculosis (MDR-TB) burden in the world (WHO 2016) . Therefore, a key purpose of the TBIMS was to strengthen the current TB control programme by reporting on care-seeking behaviour, diagnosis and treatment of all registered TB cases and to improve the quality and timeliness of data available to policy-makers, allowing better decisions on long-term TB control investments (WHO 2012) . In this article, we summarize the TBIMS system-one of the largest in the world, capturing data from 1 million TB patients annually-and discuss modifications that could generate important policy-relevant analyses to improve TB control strategies (Huang et al. 2014) .
TB control in China and the role of the TBIMS
TB control in China is organized through a decentralized semivertical system. All individuals with presumptive TB are to be referred to TB dispensaries affiliated with the CDC or hospitals with specialized TB units by physicians in general hospitals. These TB health facilities provide TB diagnostic tests, at no charge, to individuals with presumptive TB, and standardized treatment to confirmed TB patients under the DOTS strategy. Having direct access to the TBIMS, staff in TB dispensaries and designated hospitals are responsible for collecting and entering all required details of confirmed TB cases to the system within 24 h of diagnosis (Wang et al. 2009 ).
The TBIMS is set up to include all TB health facilities at province, prefecture and county level, and has thus far covered 3200 across the country with an estimated of 20 000 users entering data into the system (WHO 2012; Huang et al. 2014) .
Overview of data collection and reporting system
A list of data collected for the TBIMS is shown in Table 1 .
Strengths of TBIMS system
Good quality control and dissemination processes To ensure the timeliness, completeness and accuracy of the data, a series of quality control measures are built in. First, a set of automatic logic checks are coded into the TBIMS to alert the user if an erroneous value is entered (Huang et al. 2014) . Second, supervisors are responsible for validating data and informing staff about data issues that need addressing. To avoid unintended edits to the data, point-of-care users need to ask supervisors for permission when modification is required after patient data has been entered (WHO 2012). Finally, the system can generate aggregated reports to evaluate the timeliness and completeness of data collection across the region of interest (Huang et al. 2014) .
The China CDC publishes quarterly, semi-annual and annual analysis reports on national TB surveillance data, which is shared by Ministry of Health and all TB dispensaries at provincial level. At local level, the TB dispensaries in prefectures and counties produce quarterly, semi-annual and annual reports in which standard indicators of programme performance are generated so that performance can be compared at regional level (WHO 2012).
Partial linkage with IDRS
The TBIMS is linked partially to the IDRS, which enables data exchange between the two systems in real time. In China, most individuals with presumptive TB tend to first seek care at general hospitals (Ministry of Public Health 2002), which are required by law to report the case to the IDRS within 24 h and refer the individual to a TB health facility within the area. Once the case has been updated in the IDRS, staff at TB health facilities can be alerted by the interface linking the IDRS and the TBIMS. If the individual does not arrive within 3 days, staff at the CDC affiliated facilities are responsible for tracing patients referred to their units.
Once a referred individual with presumptive TB is diagnosed with TB, CDC staff are required to register the TB patient and update the information on the TBIMS (Huang et al. 2014) . Updated information will be transferred to the IDRS in real time so that the referring health facility knows of the patient's outcome.
Investment in human resources and infrastructure
To ensure sustainability of the TBIMS, the national government made a long-term funding plan for system administration, hardware and software maintenance. The National Center for Tuberculosis Control and Prevention-which sits within the China CDC-holds an annual conference to budget for expenditure related to operation and maintenance of the TBIMS. A long-term human resource plan is also in place, including staff training to perform data management and project support (WHO 2012).
Limitations and potential improvement
Important additional information that can be collected Although the current TBIMS system collects a range of important information and we recognize that health staff should not be overburdened by lengthy data entry for every patient, there are additional variables that could be added to improve monitoring and assessment of TB control activities.
Data on patients' first presentation to a healthcare provider are essential for calculating and evaluating delay to diagnosis, which is the critical time period between onset of symptoms and confirmation of TB. The current TBIMS only records the date of first visit (and patient registration) at a CDC affiliated health facility. If the first visit to a healthcare provider for TB-related symptoms is at a health facility not linked with the electronic reporting systems-such as private clinics, pharmacies or Traditional Chinese Medicine providers-this visit is not captured. Although relying on patients' recall of onset of symptoms can be unreliable, recording simple information about the date of first visit to any healthcare provider for TB-related symptoms, and the type of health facilities visited, will allow delay to diagnosis once patients have entered the health system to be monitored. It will also enable an analysis of whether the patient's first healthcare seeking encounter impacts treatment outcomes and whether delays to diagnosis are substantially longer for MDR-TB patients.
Although delays between symptoms and presentation at a CDC health facility and from presentation to diagnosis or treatment can be manually calculated based on information collected in the TBIMS, doctors and health facility staff rarely have time to conduct such analyses. We propose including information on delays as an automated indicator for evaluating the performance of TB control programme; key factors associated with delay to treatment initiation could also automatically be reported through a calculation of median delays in different regions and patient subgroups. Such information could be useful for doctors and health policy-makers to identify and prioritize patients that are at risk of prolonged delay.
In addition, data on all individuals with presumptive TB that are tested for TB should be analysed routinely-not just data on confirmed TB patients-as such analyses would indicate the number of individuals that need to tested before identifying a new case, and be useful for costing studies.
Linking of information on retreatment
For retreatment patients-those who have been previously treated for TB and are being recorded in the system for a second round of treatment-it is important that information about the first treatment is linked to the retreatment record. At present, the system assigns retreatment cases a new patient ID that is not linked to the ID generated for the first treatment. Since previous treatment is associated with drug-resistance (Espinal et al. 2001) , it is essential that the TBIMS allows operational research to identify specific risk factors for drug-resistance. Coordination between IDRS and TBIMS Finally, although the TBIMS and IDRS are linked, the use of a common set of unique identifiers for individuals could enhance data sharing between the databases from perspective of conducting operational research. At present identification numbers used by the two systems are different. Therefore, complete records of individual patients cannot be linked across the databases. For example, it would be useful if complete socio-demographic and clinical information on individuals with presumptive TB who were referred to the CDC health facilities but did not access those facilities was available so that characteristics of individuals that do and do not complete the referral process can be analysed. Table 2 illustrates some modifications to the TBIMS and their potential insights.
Conclusion
Continual investment in the TBIMS reflects China's commitment to addressing existing challenges in TB and wider infectious disease control. As with other routine surveillance systems, improvements can be made to allow operational research for informing policies, including better data linkages with other national surveillance systems, collection of information about delays to diagnosis, and linking information about retreatment cases to the initial episode of TB. Optimizing routine surveillance systems such as the TBIMS can provide powerful information for decision-making.
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